Momentum Stocks: AMC Short Interest Information – Plus more.
Community, I’m going to be updating this list of momentum stock and their short interest and utilization daily (AMC short interest, BBIG, MULN, BIOR, GME, APE, and many others).
Be sure to bookmark this page for daily AMC short interest updates and more.
Other metrics being updated daily will include the cost to borrow, shares on loan, + short squeeze scores.
If there are other heavily shorted stocks you’d like me to update daily, please leave a comment below and I’ll be sure to look into them before adding them to the list!
– Frank Nez
#1. BBIG Short Interest
Short Interest: 15.59% | Utilization: 100.00 | Cost To Borrow: 11.91 | Shares On Loan: 47.00 Million | Days To Cover: 6.75
BBIG Short Squeeze Score: 81
(Updated Daily)
#2. MMAT Short Interest
Short Interest: 11.27% | Utilization: 100.00 | Cost To Borrow: 21.28 | Shares On Loan: 30.21 Million | Days To Cover: 2.71
Hedge funds may be incentivized to close their short positions in AMC stock as the cost to borrow increases. At some point, it’s not worth paying that high of a fee to continue shorting a company that has fundamentally improved.
AMC is no longer the same endangered company it once was during the pandemic.
The company has improved every quarter since 2021 and has managed to get rid of most of its debt.
The world’s largest movie theatre continues to innovate and adapt to the changing world.
While online streaming threatened the industry, revenue from box office hits has proved people are still going to the movie theatres, despite the convenience of watching movies at home.
Short sellers are betting against a recovering and innovating film industry generating billions in revenue now.
As AMC continues to prove itself fundamentally and the cost to borrow rises, expect short sellers to begin closing their short positions.
Here is where patient investors will see massive returns.
AMC Short Squeeze – AMC Entertainment 2023 – AMC Stock Price – AMC Stock Squeeze
Will AMC squeeze This Year?
The Fool thinks you should sell your stock, but retail investors aren’t budging.
Mainstream media who serve hedge funds in a conflict of interest have been egging retail investors to not buy the stock all of 2021.
If you listened to The Fool who told you not to buy AMC when its share price was low, then you would have missed out on a trade that went as high as 3000% in gains!
While the runup to $72 per share might have caused AMC’s short interest to drop to 14% from 20%, AMC’s short interest has now gone up to 22%.
Ladies and gentlemen, AMC stock has plenty of room for growth in 2023.
Welcome to Franknez.com – the blog that provides retail investors market news with integrity. Today we’re discussing AMC’s short interest data to determine whether it will squeeze in 2023.
Will AMC stock squeeze in 2023? Game over short sellers | AMC Stock 2023 – AMC Stock Price
AMC has a high enough short interest to squeeze shorts from their positions in 2023.
Sitting at 22% short interest, it’s more than enough to get the price up well into the high hundreds of dollars per share.
Whether regulators will investigate naked shares, FTDs, and other forms of counterfeit shares for hedge funds to cover is another topic.
AMC will need momentum if it’s to see another massive runup in share price.
Furthermore, hedge funds will lead their customers into losses for the second year in a row if retail investors continue to buy and hold the stock in 2023.
AMC Entertainment stock has plenty of room for growth and mainstream media doesn’t want you to know it.
If you’re lucky enough to get involved in the ape community you’ll find yourself fighting for a fair and transparent market, where your voice means everything.
Reasons why AMC wont squeeze in 2023..
I’ve always been transparent with the community.
There are many of you who got in when I first began publishing the data early last year and are sitting on unrealized gains today.
And although AMC could have squeezed during various occasions last year, there are still things that can hinder AMC from squeezing this year.
Here’s a list of things that will refrain AMC from squeezing shorts from their positions:
Retail investors start selling AMC stock
Retail investors stop buying AMC stock
New buyers aren’t introduced to the stock or short interest data
The AMC community has not had a problem holding or buying the stock.
One of the biggest problems the community faces today is regulators not protecting retail investors against the predatorial strategies from hedge funds.
The community has always been a beacon for change.
Apes will need to voice market concerns to elevate awareness.
AMC stock had multiple chances to squeeze in 2021, however, hedge funds always found a loophole that would prevent them from reporting information, or trading stock in the lit exchange.
Market manipulation continues to be a threat to every retail investor in the market.
AMC Entertainment was on the brink of extinction, it was about to go bankrupt.
Hedge funds took this opportunity to overleverage their short positions in the stock, betting it would close forever.
Once retail investors got in and saved the company, the community uncovered a number of market manipulation tactics that allowed hedge funds to prevent the stock’s share price from soaring.
The fight for a fair market continues in 2023.
For the ape community, this is more than just a short squeeze play.
Your support helps maintain all the costs it takes to run a blog at this scale.
Together, we’ve been able to place AMC Entertainment articles on the #1 page results on Google and get featured on the ‘news’ section, combating mainstream media.
The mission of this platform is to spread the truth corporate media isn’t willing to, by giving the people in our community a voice.
Daily Market News: AMC stock news, updates + more.
AMC Entertainment (NYSE:AMC) stock is up more than +40% this year-to-date.
New developments this year may send share prices rising throughout 2023.
Streaming giants have figured out that the theatrical experience is key to their long-term success.
AMC Entertainment CEO Adam Aron praised Disney for scheduling Stephen King’s ‘The Boogeyman’ to be released theatrically on June 2nd, 2023.
The film was originally planned to be released on the streaming service Hulu.
“Theatres beat streamers! We salute producer 21Laps and our friends at Disney for this decision. The Boogeyman, a Stephen King adaption, was made for Hulu. But it tested so well, Disney is releasing it theatrically instead. Thank you Bob Iger, Alan Bergman, Justin, Tony, and Ken,” said Adam Aron on Twitter.
On the other end, CNBC says Netflix left $200 million on the table for not leaving Daniel Craig’s ‘Glass Onion: A Knives Out Mystery’ in theatres longer.
So, what does this say about the Wall Street short thesis that movie theatres are dead?
Here’s the latest AMC Entertainment stock market news.
Online Streaming Might Not Be What Wall Street Hoped For
Glass Onion: A Knives Out Mystery starring Daniel Craig was released in the U.S. as well as the UK, Ireland, Italy, Germany, and Spain.
CEO Adam Aron stated on Twitter that success here could lead to more Netflix (NASDAQ:NFLX) movies at AMC.
The film earned $15 million at the box office but CNBC says the showing could have made $200 million if it had been kept in theatres longer.
The sequel to Johnson’s popular “Knives Out” opened in nearly 700 theaters, the largest release of any Netflix original film to date, 200 of which were AMC Entertainment theatres.
Unfortunately for the online streaming platform, hundreds of millions of dollars were left on the table.
Box office analysts say Glass Onion could have earned much higher earnings if Netflix had opted for a traditional wide release of 2,000 to 4,000 theaters.
What Are Experts Saying?
CNBC stated, “Netflix has backtracked on its previous policies, including by introducing an ad-supported subscription option, leading many to wonder whether the company should rethink its resistance to the traditional Hollywood movie release model as it looks for new ways to grow revenue. “
Amazon insiders told Bloomberg the retail giant plans to invest billions in the movie theatre industry, aiming to release 12-15 movies annually for theatrical release.
That number of releases puts Amazon on par with major studios such as Paramount Pictures.
CNBC stated that ‘while a $1 billion annual investment for film development is on the lower end of what major Hollywood studios spend each year, it’s a positive sign for the movie theater business.”
The company capitalized on APE to cut some debt off the top before taking on new debt due in five years from now.
AMC has replaced $506 million due in 2023 with $400 million of new debt due in 2027.
The updated balance sheet is going to ensure the movie theatre chain company is able to grow while it slowly pays off its debt.
AMC Entertainment has reported positive earnings reports since 2021 when shareholders rescued the company from bankruptcy.
Today, it’s about maintaining that momentum to ensure the short thesis eventually changes.
Will APE Shares Go Up?
APE Stock Price Today – Yahoo Finance.
AMC’s Preferred Equity (APE) is up 50% this year-to-date.
The equity saw massive buying volume in the beginning of the new year which led to a great head start this year.
This type of buying pressure will continue to drive APE shares up in the future, that is unless majority of shareholders decide not to convert the equity into common shares of AMC stock.
Today, APE is trading around $1.80 and is up +2% in the past five trading days.
While there are still short sellers betting against the equity, AMC Entertainment has warned both retail investors of possible and significant losses due to volatility and the possibility of a short squeeze.
Are you holding shares of AMC’s Preferred Equity (APE)?
Leave your thoughts in the comment section of the blog below.
Market News Published Daily
FrankNez News Today – Market News, Business News, + more.
For more stock market, business news and updates,join the newsletter to receive weekly market news and notifications straight to your inbox.
Franknez.com is the media blog that keeps retail investors informed.
The forecast is ambitious without a doubt, but the company shows great signs of scalable growth both in the near- and long-term future.
Mullen Automotive recently partnered with Loop Global to deploy EV charging solutions, including a public DC fast charging network and residential offerings.
The company is also preparing for 3 commercial product launches in 2023 after signing with their first U.S dealer partner, RMA Group.
In early December, the company also announced Former General Motors Government Sales Leader Ronald Dixon will be leading Mullen’s EV charge for U.S government fleet sales.
Mullen Automotive is expected to grow substantially in 2023.
Investors Remain Bullish on MULN Stocktwits Forum
Retail investors on the MULN Stocktwits forum and other social media platforms are preparing to collect massive gains as technicals align with upcoming bullish momentum.
The stock closed at $0.33 on Wednesday (1/11) after surging +4.35% from its previous trading day.
Mullen Automotive had a market capitalization of $437.7 million at the end of December 2022 but has increased its market cap to $524.9 million in only the second trading day of 2023.
If the company’s market cap continues to grow this rapidly then retail investors will begin to see exponential growth in their investment.
Call options in MULN stock have also overwhelmingly taken over the number of put options contracts.
MULN Stock Call Options – MULN Stocktwits Forum – Franknez.com.
On Wednesday there were a total of 59.91K call options versus 1.85K put options.
Significantly more investors are betting on MULN shares to rise than they’re betting on the stock to decline.
But that’s not all, the market sentiment only gets stronger for bulls going long on Mullen Automotive.
Financial institutions have also begun to bulk up on their long positions.
Let’s take a look at a few names you might be familiar with.
Which Financial Institutions Are Buying MULN Stock?
Two of the biggest financial institutions that have recently bulked up on MULN stock have been Vanguard and BlackRock.
Best of all, out of 173 financial institutions investing in Mullen Automotive, only 1 is short with 172 being long, per Fintel.
In December alone, 18 financial institutions purchased shares of Mullen Automotive.
MULN stock institutional buyers | Who is buying MULN stock?
Other major institutional buyers include Fidelity, the Russel 2000 index, Nationwide Mutal Funds, Schwab, Morningstar, and Blackstone.
Similarly, we saw financial institutions beginning to go long on AMC Entertainment stock in 2021 before it shot up more than +3,000%.
Although the company stock was still being shorted, the massive buying pressure from both retail investors and institutions was powerful enough to drive shares sky high.
Are you holding shares of Mullen Automotive?
MULN stock prediction, news, updates, + more on Franknez.com.
Share your thoughts below.
Have you been a longtime shareholder, or have you recently come across this stock ticker?
For more MULN stock news and updates,join the newsletter to receive weekly market news and notifications straight to your inbox.
Stock Market News: What’s happening with MULN stock? Will MULN shares keep rising?
Mullen Automotive (NASDAQ:MULN) stock shares rose +2.27% on Monday after a turbulent past few days last week.
The automotive stock surged to $0.44 before in January before retesting $0.28 and closing at $0.30 the start of the new week.
Retail investors have been buying the stock after analysts gave MULN stock a price target of $24.15.
The current analyst consensus is a strong buy, but shares fell after Mullen Automotive submitted its Form 10-K on Friday the 13th, revealing a number of risk factors.
Will Mullen Automotive stock recover?
Here’s what’s happening with MULN stock right now.
MULN Call Options Continue to Dominate Put Options
Even as MULN shares make gains and slide in January, we see that MULN call options continue to dominate the number of put options in the market.
On Monday, there were 96.41K calls total and 1.64K puts total.
This demonstrates there are more bullish investors than there are bearish investors.
Market News: At least 30% of GameStop shareholders have registered their shares.
GameStop says at least 30% of its shareholders have registered their shares with the Direct Registration System (DRS).
According to the filing, approximately 30% of GME’s float is registered equating, to 71.3 million shares.
The efforts from retail investors come as a means to prevent manipulative short seller attacks.
GME stock is trading at $21.66 on Monday with trading volume surpassing the company’s average volume of 5.1 million.
Shares of GameStop (NYSE:GME) are up +26% this year-to-date, a great start to the new year.
On Monday, GameStop shares have risen more than 11% intraday where shares rose to nearly $22.50.
GME’s short interest is currently sitting at 23.55% with approximately 95 million shares out on loan.
This means that despite DRS, the game retailer continues to be heavily shorted.
GameStop Ownership Structure
How much of GameStop’s float is owned by retail investors?
Nearly 70% of the float is owned by individual shareholders according to Vickers Stock Research.
GameStop Ownership Structure – Franknez.com.
This means nearly 40% of retail investors have not registered their GameStop shares through DRS.
Yet it’s very possible the percentage of GameStop shareholders who have registered their shares has grown in the past months.
GameStop’s Chair Ryan Cohen himself owns more than 12% of GME shares.
These are held through Ryan’s holding company RC Ventures, which Vickers considers to be Institutional ownership (12% on graph).
Is DRS working out for GameStop shareholders?
It very well could be, considering GME shares are up nearly +26% this year despite having a high short interest rate.
AMC Entertainment (NYSE:AMC) stock on the other hand is up +44% this year despite DRS being significantly less popular within shareholders.
The movie theatre stock is also heavily shorted at 21.96%.
And according to AMC’s CEO, roughly 90% of shareholders own the float.
Where is GameStop headed in 2023?
30% of GameStop Shareholders have registered their shares according to GameStop.
GME stock has the potential to have a big year in 2023.
GameStop continues to be a popular company amongst retail investors, primarily due to the massive community of shareholders who are looking to squeeze short sellers again.
During the spark of the ‘meme stock’ frenzy, GameStop shares rose to $483 per share, a superior all-time high.
But shareholders are not convinced the stock is done running.
2023 opens up new possibilities for GameStop as e-commerce, NFTs, and Web 3.0 gaming continues to grow.
While the company may benefit from arming itself with more short-term capital, GameStop enters the new year with positive cash flow, an incredible start for the company as many continue to struggle.
BIOR stock is up more than +71% this year-to-date but surged as much as +182% during the first trading week of January.
Formerly known as ‘Progenity’ (PROG), Biora Therapeutics stock is currently trading at $4.12.
The company may be heavily shorted, but there’s big opportunity for retail investors if the company’s clinical trials go well.
And so far, the company seems to be on track.
A big announcement such as the approval of their therapeutics program could trigger short sellers to run for the hills, initiating a short squeeze in Biora Therapeutics.
Will BIOR stock go up to its hundreds of dollars per share IPO levels again?
Here’s the latest BIOR stock news.
BIOR Stock News Today
BIOR Stock Short Interest + news today.
Biora Therapeutics is on track to move into clinic with its lead targeted therapeutics program.
For Biora’s Targeted Therapeutics Platform, which is focused on treatment of ulcerative colitis (UC), the company remains on track for an IND filing for its PGN-600 program followed by clinical trial initiation.
During Q4 2022, Biora continued its engagement with the FDA with a pre-IND supplemental Type C filing requesting agency feedback on its proposed PGN-600 clinical development plans, including the company’s proposed approach to toxicity studies and other aspects of its clinical plan.
“The recent Type C response from the FDA further strengthens our confidence in our plans to enter the clinic during the first half of 2023 with IND filing followed by trial initiation in Q2, and data readouts anticipated in Q3,” said Adi Mohanty, Chief Executive Officer of Biora Therapeutics.
For Biora’s Systemic Therapeutics program, the company has been transitioning from early concept to a clinical-ready device.
With several of the key device upgrades implemented, the company expects to report data from preclinical studies on its next-generation device during Q1 and Q2 of 2023.
If clinical trials prove to be a success, Biora Therapeutics’ platform will be approved for use.
![Will AMC Stock Squeeze This Year? [Short Interest Data]](https://i0.wp.com/franknez.com/wp-content/uploads/2022/01/Will-AMC-Squeeze-in-2022.jpg?resize=40%2C40&ssl=1){kind=small}
Are you prepared for a recession? Leave your thoughts below.